Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set

Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set

Background: Retroperitoneal lymph node dissection (RPLND) is essential for the treatment of metastatic germ cell tumours of the testis. Recommendations on the referral and management of complex urological cancers in the UK includes centralisation of services to regional centres. Objective: To review...

Full description

Bibliographic Details
Main Authors: Adam Kieran Pearce, David Manson-Bahr, Alison Reid, Robert Huddart, Erik Mayer, David L. Nicol
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:European Urology Open Science
Subjects:
Retroperitoneal lymph node dissection
Germ cell tumours
Testis cancer
Postchemotherapy
Outcomes
Centralisation
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168321006777

Internet

http://www.sciencedirect.com/science/article/pii/S2666168321006777

Similar Items